The EDQM/European Pharmacopoeia (Ph. Eur.) and the Indian Pharmacopoeia Commission (IPC) held a symposium in Mumbai to discuss the quality control of medicines in the context of the pharmaceutical legislation and regulatory requirements that exist in Europe and India.

The event was attended by authorities and manufacturers alike, in particular those involved in the manufacture of APIs, from production, quality control and regulatory affairs. The programme covered an overview of the roles of the EDQM/ Ph. Eur. and the IPC in the quality control of medicines including harmonisation activities. Practical advice was also given on using and interpreting the European Pharmacopoeia General Chapters and Monographs, together with an overview of the policies and processes used to establish Pharmaceutical Reference Standards.

Discussions also covered the EDQM’s Procedure for Certification of Suitability, or CEP as it is more commonly known.

• Read the press release
• More information on the Work of the Pharmacopoeial Discussion Group (PDG)
• More information about the Procedure for Certification of Suitability